Search Browse Earnings

Third Harmonic Bio, Inc. — SlamSEC

Third Harmonic Bio, Inc.

Pharmaceutical Preparations·SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$43.9M

FY 2024

Net Income

-$30.8M

FY 2024

EPS (Diluted)

$0.78

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$269.1M

FY 2024

Total Debt

—

Net Cash

$269.1M

Enterprise Value

—

Debt / EBITDA

6.1x

FY 2024

EV / EBITDA

—

Employees

—